MannKind (MNKD) EPS Estimated At $-0.23; Cross Country Healthcare (CCRN) Has 0.89 Sentiment

April 29, 2018 - By Peter Mason

MannKind Corporation (NASDAQ:MNKD) Logo

Analysts expect MannKind Corporation (NASDAQ:MNKD) to report $-0.23 EPS on May, 9.They anticipate $0.01 EPS change or 4.55% from last quarter’s $-0.22 EPS. After having $-0.28 EPS previously, MannKind Corporation’s analysts see -17.86% EPS growth. The stock decreased 1.16% or $0.02 during the last trading session, reaching $1.7. About 1.20M shares traded. MannKind Corporation (NASDAQ:MNKD) has risen 37.36% since April 29, 2017 and is uptrending. It has outperformed by 25.81% the S&P500.

Cross Country Healthcare Inc (CCRN) investors sentiment decreased to 0.89 in Q4 2017. It’s down -1.13, from 2.02 in 2017Q3. The ratio has dropped, as 58 institutional investors increased or opened new equity positions, while 65 sold and reduced positions in Cross Country Healthcare Inc. The institutional investors in our database now hold: 32.44 million shares, down from 33.17 million shares in 2017Q3. Also, the number of institutional investors holding Cross Country Healthcare Inc in top ten equity positions was flat from 1 to 1 for the same number . Sold All: 20 Reduced: 45 Increased: 40 New Position: 18.

MannKind Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic products for diabetes diseases in the United States. The company has market cap of $249.99 million. The Company’s approved product is Afrezza, a rapid-acting, inhaled insulin used to control high blood sugar in adults with type 1 and type 2 diabetes. It currently has negative earnings.

Among 7 analysts covering Mannkind (NASDAQ:MNKD), 2 have Buy rating, 4 Sell and 1 Hold. Therefore 29% are positive. Mannkind had 16 analyst reports since August 3, 2015 according to SRatingsIntel. The rating was downgraded by Maxim Group on Wednesday, November 1 to “Hold”. H.C. Wainwright maintained it with “Buy” rating and $7.0 target in Wednesday, November 8 report. The firm earned “Underweight” rating on Wednesday, January 6 by Piper Jaffray. The rating was downgraded by Vetr on Friday, August 28 to “Strong-Buy”. As per Wednesday, September 9, the company rating was downgraded by Piper Jaffray. The rating was downgraded by Maxim Group to “Sell” on Wednesday, February 28. The firm earned “Buy” rating on Friday, August 11 by Maxim Group. Maxim Group maintained MannKind Corporation (NASDAQ:MNKD) on Friday, September 1 with “Buy” rating. The firm has “Underperform” rating by RBC Capital Markets given on Wednesday, November 4. As per Monday, August 3, the company rating was maintained by RBC Capital Markets.

Hawk Ridge Capital Management Lp holds 3.52% of its portfolio in Cross Country Healthcare, Inc. for 829,582 shares. Alphaone Investment Services Llc owns 457,438 shares or 1.76% of their US portfolio. Moreover, Skyline Asset Management Lp has 1.1% invested in the company for 1.07 million shares. The Massachusetts-based Aristotle Capital Boston Llc has invested 0.9% in the stock. Eagle Boston Investment Management Inc, a Massachusetts-based fund reported 701,118 shares.

Since January 1, 0001, it had 2 insider purchases, and 1 sale for $52,853 activity.

Analysts await Cross Country Healthcare, Inc. (NASDAQ:CCRN) to report earnings on May, 2 after the close. They expect $0.02 EPS, down 60.00% or $0.03 from last year’s $0.05 per share. CCRN’s profit will be $723,135 for 160.75 P/E if the $0.02 EPS becomes a reality. After $0.17 actual EPS reported by Cross Country Healthcare, Inc. for the previous quarter, Wall Street now forecasts -88.24% negative EPS growth.

The stock increased 0.86% or $0.11 during the last trading session, reaching $12.86. About 80,617 shares traded. Cross Country Healthcare, Inc. (CCRN) has declined 18.85% since April 29, 2017 and is downtrending. It has underperformed by 30.40% the S&P500.

Cross Country Healthcare, Inc. provides healthcare staffing, recruiting, and workforce solutions in the United States. The company has market cap of $464.98 million. The firm operates through three divisions: Nurse and Allied Staffing, Physician Staffing, and Other Human Capital Management Services. It has a 12.69 P/E ratio. The Nurse and Allied Staffing segment offers traditional staffing, including temporary and permanent placement of travel nurses and allied professionals, and branch local nurses and allied staffing; and short-term staffing of registered nurses, licensed practical nurses, certified nurse assistants, practitioners, pharmacists, and other allied professionals on per diem and short-term assignments.

Cross Country Healthcare, Inc. (NASDAQ:CCRN) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 Peter Mason

Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: